Patents by Inventor Olaf Bork
Olaf Bork has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210172001Abstract: The present invention provides compositions, methods and kits for bacteria identification and anti-microbial susceptibility testing for the treatment of, for example, acute and chronic infections including infectious disease. The present invention is particularly useful in the identification of bacteria causing mastitis, and to antibiotic susceptibility testing to facilitate in the identification of an appropriate treatment for mastitis.Type: ApplicationFiled: September 29, 2020Publication date: June 10, 2021Inventor: Olaf Bork
-
Patent number: 10828311Abstract: The present invention relates to a composition, the composition including a therapeutically effective amount of at least one active agent, and a base including, an amount of colloidal silica; at least one oil; and at least one surfactant, wherein the viscosity of the composition is below 1000 mPas at a shear rate of 100 l/s and at a temperature of 20° C.Type: GrantFiled: February 27, 2013Date of Patent: November 10, 2020Assignee: BAYER NEW ZEALAND LIMITEDInventors: Fadil Al Alawi, Olaf Bork, Ian George Tucker
-
Patent number: 10829796Abstract: The present invention provides compositions, methods and kits for bacteria identification and anti-microbial susceptibility testing for the treatment of, for example, acute and chronic infections including infectious disease. The present invention is particularly useful in the identification of bacteria causing mastitis, and to antibiotic susceptibility testing to facilitate in the identification of an appropriate treatment for mastitis.Type: GrantFiled: February 26, 2016Date of Patent: November 10, 2020Assignee: MASTAPLEX LIMITEDInventor: Olaf Bork
-
Patent number: 10677811Abstract: A sample receptacle including one or more receptacle cavities each having an opening dimensioned such that a liquid within the cavity is retained when the cavity opening is oriented downwardly and/or a gas vent in the base of each cavity sized and positioned to allow gases contained within the cavity to egress whilst preventing the egress of liquid at atmospheric pressure. A sample liquid may be poured into the sample receptacle so that the level of the sample liquid is above each cavity opening and the sample receptacle inverted so as to remove liquid above each cavity whilst retaining sample liquid in each sample receptacle when inverted. This may be used for sample separation or to provide relatively uniform sample volumes to sample wells of a sample container when mated. In another embodiment plungers may be used to eject liquid from receptacle wells via an aperture in the base of each receptacle well.Type: GrantFiled: February 26, 2016Date of Patent: June 9, 2020Assignee: Mastaplex Ltd.Inventor: Olaf Bork
-
Patent number: 10376585Abstract: This invention relates to a composition, including penethamate (PNT) or a pharmaceutical equivalent thereof; and at least one oily vehicle.Type: GrantFiled: July 16, 2013Date of Patent: August 13, 2019Assignee: BAYER NEW ZEALAND LTDInventors: Fadil Al Alawi, Olaf Bork, Rohit Jain, Karthigeyan Nanjan, Ian George Tucker
-
Publication number: 20180245124Abstract: The present invention provides compositions, methods and kits for bacteria identification and anti-microbial susceptibility testing for the treatment of, for example, acute and chronic infections including infectious disease. The present invention is particularly useful in the identification of bacteria causing mastitis, and to antibiotic susceptibility testing to facilitate in the identification of an appropriate treatment for mastitis.Type: ApplicationFiled: February 26, 2016Publication date: August 30, 2018Inventor: Olaf Bork
-
Publication number: 20180149670Abstract: A sample receptacle including one or more receptacle cavities each having an opening dimensioned such that a liquid within the cavity is retained when the cavity opening is oriented downwardly and/or a gas vent in the base of each cavity sized and positioned to allow gases contained within the cavity to egress whilst preventing the egress of liquid at atmospheric pressure. A sample liquid may be poured into the sample receptacle so that the level of the sample liquid is above each cavity opening and the sample receptacle inverted so as to remove liquid above each cavity whilst retaining sample liquid in each sample receptacle when inverted. This may be used for sample separation or to provide relatively uniform sample volumes to sample wells of a sample container when mated. In another embodiment plungers may be used to eject liquid from receptacle wells via an aperture in the base of each receptacle well.Type: ApplicationFiled: February 26, 2016Publication date: May 31, 2018Inventor: Olaf BORK
-
Publication number: 20150174248Abstract: This invention relates to a composition, including penethamate (PNT) or a pharmaceutical equivalent thereof; and at least one oily vehicle.Type: ApplicationFiled: July 16, 2013Publication date: June 25, 2015Inventors: Fadil Al Alawi, Olaf Bork, Rohit Jain, Karthigeyan Nanjan, Ian George Tucker
-
Publication number: 20150045337Abstract: The present invention relates to a composition, the composition including a therapeutically effective amount of at least one active agent, and a base including, an amount of colloidal silica; at least one oil; and at least one surfactant, wherein the viscosity of the composition is below 1000 mPas at a shear rate of 100 l/s and at a temperature of 20° C.Type: ApplicationFiled: February 27, 2013Publication date: February 12, 2015Inventors: Fadil Al Alawi, Olaf Bork, Ian George Tucker
-
Publication number: 20130178390Abstract: The present invention concerns a system, comprising bacteriophages and particles comprising active agents, in which a first additional peptide is fused to proteins of the bacteriophage, the first additional peptide adheres to the surface of the particle and furthermore a second additional peptide is fused to proteins of the bacteriophage. The second additional peptide can adhere on substrate surfaces. The present invention furthermore concerns the use of the system for delayed release of active agents and also a method for production of the system. The present invention furthermore concerns a method for the selection of phage species from a combinatorial phage population.Type: ApplicationFiled: January 18, 2013Publication date: July 11, 2013Applicant: BAYER TECHNOLOGY SERVICES GMBHInventors: STEFANIE EIDEN, I, AXEL EBLE, MARTIN WEISS, DANIEL GORDON DUFF, OLAF BORK, HOLGER EGGER, BASTIAN BUDDE, SASCHA PLUG
-
Patent number: 8399236Abstract: The present invention concerns a system, comprising bacteriophages and particles comprising active agents, in which a first additional peptide is fused to proteins of the bacteriophage, the first additional peptide adheres to the surface of the particle and furthermore a second additional peptide is fused to proteins of the bacteriophage. The second additional peptide can adhere on substrate surfaces. The present invention furthermore concerns the use of the system for delayed release of active agents and also a method for production of the system. The present invention furthermore concerns a method for the selection of phage species from a combinatorial phage population.Type: GrantFiled: August 1, 2008Date of Patent: March 19, 2013Assignee: Bayer Technology Services GmbHInventors: Stefanie Eiden, Axel Eble, Martin Weiss, Daniel Gordon Duff, Olaf Bork, Holger Egger, Bastian Budde, Sascha Plug
-
Patent number: 7919004Abstract: A method for removing at least one reflective layer (4a, 4b) from an optical element (1) for EUV lithography, wherein the optical element (1) has a substrate (2) and an interlayer (6) between the substrate (2) and the at least one reflective layer (4a, 4b). The method includes etching away the at least one reflective layer (4a, 4b) as far as the interlayer (6) with an etching gas (7), wherein the material of the interlayer (6) does not react with the etching gas (7), and wherein, after the etching away, the interlayer (6) has a surface roughness of less than 0.5 nm rms, preferably of less than 0.2 nm rms, and more preferably of less than 0.1 nm rms. Also, an optical element (1) for reflecting radiation in the EUV wavelength range includes a substrate (2), at least one reflective layer (4a, 4b), and an interlayer (6) arranged between the substrate (2) and the at least one reflective layer (4a, 4b).Type: GrantFiled: August 3, 2009Date of Patent: April 5, 2011Assignee: Carl Zeiss SMT GmbHInventors: Martin Weiser, Olaf Bork, Ulrich Andiel
-
Publication number: 20100285136Abstract: The present invention concerns a system, comprising bacteriophages and particles comprising active agents, in which a first additional peptide is fused to proteins of the bacteriophage, the first additional peptide adheres to the surface of the particle and furthermore a second additional peptide is fused to proteins of the bacteriophage. The second additional peptide can adhere on substrate surfaces. The present invention furthermore concerns the use of the system for delayed release of active agents and also a method for production of the system. The present invention furthermore concerns a method for the selection of phage species from a combinatorial phage population.Type: ApplicationFiled: August 1, 2008Publication date: November 11, 2010Applicant: Bayer Technology Services GMBHInventors: Stefanie Eiden, Axel Eble, Martin Weiss, Daniel Gordon Duff, Olaf Bork, Holger Egger, Bastian Budde, Sascha Plug
-
Publication number: 20100027106Abstract: A method for removing at least one reflective layer (4a, 4b) from an optical element (1) for EUV lithography, wherein the optical element (1) has a substrate (2) and an interlayer (6) between the substrate (2) and the at least one reflective layer (4a, 4b). The method includes etching away the at least one reflective layer (4a, 4b) as far as the interlayer (6) with an etching gas (7), wherein the material of the interlayer (6) does not react with the etching gas (7), and wherein, after the etching away, the interlayer (6) has a surface roughness of less than 0.5 nm rms, preferably of less than 0.2 nm rms, and more preferably of less than 0.1 nm rms. Also, an optical element (1) for reflecting radiation in the EUV wavelength range includes a substrate (2), at least one reflective layer (4a, 4b), and an interlayer (6) arranged between the substrate (2) and the at least one reflective layer (4a, 4b).Type: ApplicationFiled: August 3, 2009Publication date: February 4, 2010Applicant: Carl Zeiss SMT AGInventors: Martin WEISER, Olaf Bork, Ulrich Andiel
-
Publication number: 20090317468Abstract: The invention relates to molded article that contains active substances and comprises at least two compartments that have a different material composition. Each compartment is independently provided with at least one active substance that is contained in a matrix. Each matrix encompasses at least one filler at a concentration of ?20 percent by weight to ?100 percent by weight relative to the total weight of the respective matrix. The invention further relates to a method for producing such molded articles as well as the use thereof.Type: ApplicationFiled: July 7, 2007Publication date: December 24, 2009Applicant: BAYER TECHNOLOGY SERVICES GMBHInventors: Claudia Letmathe, Axel Eble, Olaf Bork